Locations
Palo Alto, CA, USA · Mountain View, CA, USA · Kraków, Poland
industry
Artificial Intelligence (AI) · Biotechnology · Biotechnology Research · Machine Learning · Medical · Veterinary
Size
11 - 50 employees
Stage
Series A
founded in
2017
ImpriMed is a company that creates individualized drug response prediction technology to help veterinarians fight lymphoma. The company's technology provides precision medicine techniques that allow veterinary oncologists to find appropriate anticancer drugs by developing a patient-derived database for pet cancer treatment that can eventually be translated into human cancer care, allowing doctors to decide on a final treatment regimen based on a data-driven prediction of response success in each individual patient's body.
Something looks off?